N@N

OSUR, ARRS, OFC, ELN, PTSI, LAB Expected To Be Down Before Next Earnings Releases

^{Published on 2011-02-07 06:31:15 - WOPRAI}
 

February 7, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and February earnings reports. ORASURE TECHNOLOGIES INC (NASDAQ:OSUR), ARRIS GROUP INC (NASDAQ:ARRS), CORPORATE OFFICE PROPERTIES (NYSE:OFC), ELAN CORP PLC -SPONS ADR (NYSE:ELN), P.A.M. TRANSPORTATION SVCS (NASDAQ:PTSI), LABRANCHE & CO INC (NYSE:LAB) are all expected to be Down Before their earnings are released . The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released :

     Symbol     Company                             # of Reports            Quarter     Release Date
     OSUR       ORASURE TECHNOLOGIES INC            12 Quarter              Q           02/09/2011
     ARRS       ARRIS GROUP INC                     12 Quarter              Q           02/09/2011
     OFC        CORPORATE OFFICE PROPERTIES         6 Quarter               Q           02/09/2011
     ELN        ELAN CORP PLC -SPONS ADR            6 Quarter               Q           02/08/2011
     PTSI       P.A.M. TRANSPORTATION SVCS          6 Quarter               Q           02/08/2011
     LAB        LABRANCHE & CO INC                  6 Quarter               Q           02/08/2011

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

ORASURE TECHNOLOGIES INC (NASDAQ:OSUR) - OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. Its products include OraQuick ADVANCE HIV-1/2, a point-of-care test for antibodies to the human immunodeficiency virus type 1 and type 2; OraQuick HCV, a point-of-care test for antibodies to the hepatitis C virus; OraSure, an oral fluid collection device for the detection of antibodies to HIV-1; and Intercept, an oral fluid collection device for oral fluid drugs of abuse testing. The company also offers MICRO-PLATE DOA Assays used to detect drugs in an oral fluid sample; Cryosurgical SystemsProfessional under the Histofreezer trade name for the removal of warts and other benign skin lesions; and Cryosurgical SystemsOTC for the removal of common and plantar warts. In addition, it develops OraQuick HIV-1/2 OTC, a point-of-care oral fluid HIV-1/2 test; Homogeneous DOA Assays; and OraQuick, a point-of-care testing platform. Further, the company sells immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid western blot HIV-1 confirmatory test; and Q.E.D., a rapid point-of-care saliva alcohol test. Additionally, it offers various diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types, and other medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The company markets its products through direct sales, strategic collaborations, and independent distributors to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians offices, and commercial and industrial entities in the United States and internationally. It has collaboration agreements with Merck & Co. Inc. and Roche Diagnostics. The company was founded in 1979 and is based in Bethlehem, Pennsylvania.

ARRIS GROUP INC (NASDAQ:ARRS) - ARRIS Group, Inc. develops, manufactures, and supplies telephony, data, video, construction, rebuild, and maintenance equipment for the broadband communications industry worldwide. It operates in three segments: Broadband Communications Systems (BCS); Access, Transport, & Supplies (ATS); and Media & Communications Systems (MCS). The BCS segment offers VOIP and high speed data products, including CMTS edge router, 2-line residential EMTA, multi-line EMTA for residential and commercial services, wireless gateway EMTA, and high speed data cable modems; and video/IP products, such as CMTS edge router, universal EdgeQAM, and whole home DVR. It also provides video processing products that comprise digital video encoders and multiplexers; and transcoders, transraters, and statistical multiplexers. The ATS segment offers hybrid fiber-coaxial plant equipment products comprising headend and hub products, optical transmitters, optical amplifiers, optical repeaters, optical nodes, ePON optical network units, ePON optical line terminals, RF over glass optical network units, and radio frequency products; and infrastructure products for fiber optic or coaxial networks, including cable and strand, vaults, conduit, drop materials, tools, connectors, and test equipment. The MCS segment offers content and operations management systems, such as products for video on demand, ad insertion, and digital advertising; operations management systems, including products for service assurance, service fulfillment, and mobile workforce management; and fixed mobile convergence network comprising products for mobility application server for continuity of services across wireless and packetcable networks, and voice call continuity application server for continuity of services in IP multimedia subsystem networks. ARRIS markets its products primarily to cable system operators and multiple system operators. The company was founded in 1969 and is headquartered in Suwanee, Georgia.

CORPORATE OFFICE PROPERTIES (NYSE:OFC) - Corporate Office Properties Trust, a real estate investment trust (REIT), engages in the acquisition, development, ownership, management, and leasing of suburban office properties. As of December 31, 2005, the companys portfolio consisted of 165 office properties; 14 wholly owned office properties under construction or development; and land parcels totaling 311 acres. As of the above date, the company, through joint ventures, owned 18 operating properties, 2 office properties, and land parcels totaling 138 acres. As an REIT, it would not be taxed on the portion of its income, which is distributed to shareholders, provided it distributes at least 90% of its taxable income. Corporate Office Properties Trust was founded in 1988 and is based in Columbia, Maryland.

ELAN CORP PLC -SPONS ADR (NYSE:ELN) - Elan Corporation, plc operates as a neuroscience-based biotechnology company primarily in Ireland and the United States. It operates in two segments, BioNeurology and Elan Drug Technologies (EDT). The BioNeurology segment engages in the research, development, and commercial activities primarily in the areas of Alzheimers disease, Parkinsons disease, multiple sclerosis (MS), Crohns disease, and severe chronic pain. Its offers Tysabri to treat relapsing forms of MS; Prialt, a non-opioid and intrathecal analgesic for the treatment of severe chronic pain, principally neuropathic pain; Azactam, a monobactam to treat pneumonia, post-surgical infections, and septicemia; and Maxipime, an injectable cephalosporin antibiotic used to treat patients with serious and/or life-threatening infections. This segment in collaboration with Biogen Idec, Inc., develops and markets Tysabri for the treatment for Crohns disease. It also develops beta amyloid immunotherapies for the treatment of Alzheimers disease through collaboration with Wyeth. In addition, this segment develops ELND005, a novel therapeutic agent, which is in Phase II clinical study to treat Alzheimers disease; ELND006, a small molecule gamma secretase inhibitor is in Phase I clinical studies for the treatment of Alzheimers disease; and Beta secretase, a precursor to plaque development in the brain. Further, BioNeurology segment has collaboration agreement with PharmatrophiX to develop small molecule ligands for growth factor receptors relevant to neurological disorders. The EDT segment offers pharmaceutical products using its proprietary drug technologies. It also provides formulation development services and contract manufacturing services that include analytical development, clinical trial manufacturing, scale-up, product registration support, and supply chain management. Elan Corporation sells its products primarily to drug wholesalers. The company was founded in 1969 and is headquartered in Dublin, Ireland.

P.A.M. TRANSPORTATION SVCS (NASDAQ:PTSI) - P.A.M. Transportation Services, Inc., a truckload dry van carrier, engages in transporting general commodities. The companys freight consists primarily of automotive parts and consumer goods, such as general retail store merchandise, as well as manufactured goods, which include heating and air conditioning units. It also provides brokerage and logistics services, which include transportation scheduling, routing, mode selection, transloading, and other value added services related to the transportation of freight. The company offers its services in the continental United States, as well as in certain Canadian provinces and Mexico. As of December 31, 2009, it operated a fleet of 1,731 trucks and 4,630 trailers. The company was founded in 1979 and is headquartered in Tontitown, Arkansas.

LABRANCHE & CO INC (NYSE:LAB) - LaBranche & Co Inc., through its subsidiaries, operates as a registered broker-dealer. It operates as market-maker in options, futures, and exchange-traded funds (ETF) traded on various exchanges. The company operates in two segments, Market-Making and Institutional Brokerage. The Market-Making segment operates as a market maker in equity, index and ETF options, ETFs, and futures on the NYSE Amex Exchange, the NYSE Arca Exchange, the New York Board of Trade, the Philadelphia Stock Exchange, and the Chicago Board Options Exchange; broker-dealer registered with the United Kingdoms Financial Securities Authority; market maker for ETFs traded on the London Stock Exchange, and the Euroex and Euronext Exchanges; broker-dealer with Hong Kongs Securities and Futures Commission; and market maker for ETFs in Hong Kong, as well as engages in hedging transactions in Asia. The Institutional Brokerage segment provides securities execution, fixed income, and professional trading brokerage services to institutional investors and professional traders; and operates as a market maker in over-the-counter, bulletin board, and pink sheet securities. This segment also engages in agency business that trades high-yield debt for its institutional customers, as well as acts as an agent in transactions related to leveraged loans and commercial loans. The company was founded in 1924 and is based in New York, New York.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641